Use of cetuximab as an adjuvant agent to radiotherapy and surgery in recessive dystrophic epidermolysis bullosa with squamous cell carcinoma.

British Journal of Dermatology

PubMedID: 23398414

Kim M, Li M, Intong LR, Tran K, Melbourne W, Marucci D, Bucci J, de Souza P, Mallesara G, Murrell DF. Use of cetuximab as an adjuvant agent to radiotherapy and surgery in recessive dystrophic epidermolysis bullosa with squamous cell carcinoma. Br J Dermatol. 2013;169(1):208-10.
An abstract is not available. Please access the article through the links below.